WeightWatchers Med+ is now offering an oral GLP-1 medication for weight loss. The new daily pill is the first FDA-approved oral GLP-1 for weight management. Clinical trials showed weight loss results ...
GoodRx announced Wednesday that eligible Wegovy users will be able to access the newly approved higher 7.2-mg dose injection for $399 per month. The platform is giving eligible self-pay patients ...
Novo Nordisk launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients pay lower, "predictable" monthly prices. Eligible patients can ...
Medicare's new $50 monthly Wegovy program sounds like a lifeline, but the eligibility rules quietly shut out many of the people who expect to qualify first, including some with common diagnoses who ...
The MarketWatch News Department was not involved in the creation of this content. -- New subscription-based option helps eligible self-pay patients start and stay on Wegovy(R) with predictable pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results